Martek Announces Addition to Its Board of Directors

COLUMBIA, Md., Jan. 22 /PRNewswire-FirstCall/ -- Martek Biosciences
(Nasdaq: MATK) today announced the election of Robert H. Mayer to its board of
directors.
Mr. Mayer brings an extensive domestic and international business
background to Martek's board having served from 1981 to 2007 in a variety of
executive capacities for Danisco A/S, one of the world's leading producers of
ingredients for food and other consumer products. In his most recent executive
role, Mr. Mayer served as chief executive officer and chairman of the board
for Genencor International, Inc., a wholly-owned subsidiary of Danisco A/S
specializing in the development and manufacture of industrial enzymes.
Mr. Mayer holds a doctorate in chemical engineering from the Massachusetts
Institute of Technology and a bachelor of science degree in chemical
engineering from Columbia University. He also currently serves on the board
of directors of Kalsec, Inc., a privately-held food additive company.
"We are pleased to welcome Robert Mayer to Martek's board," said Steve
Dubin, CEO of Martek. "Bob's extensive experience in the food and
biotechnology industries as well as his many years spent in senior management
positions provides Martek with a valuable resource."
Martek Biosciences Corporation (Nasdaq: MATK) is a leader in the
innovation and development of DHA omega-3 products that promote health and
wellness through every stage of life. The company produces life'sDHA(TM), a
sustainable and vegetarian source of the omega-3 fatty acid DHA
(docosahexaenoic acid), for use in foods, beverages, infant formula, and
supplements. The company also produces life'sARA(TM) (arachidonic acid), an
omega-6 fatty acid, from a sustainable, vegetarian source, for use in infant
formula. For more information on Martek Biosciences Corporation, visit
http://www.martek.com.
CONTACT
Cassie France-Kelly
Public Relations
(443) 542-2116
media@martek.com

Kyle Stults
Investor Relations
(410) 740-0081
investors@martek.com

SOURCE Martek Biosciences

Cassie France-Kelly, Public Relations, +1-443-542-2116, media@martek.com, or
Kyle Stults, Investor Relations, +1-410-740-0081, investors@martek.com, both
of Martek Biosciences